Stay updated on Anemia in CKD: Daprodustat ASCEND-TD Clinical Trial
Sign up to get notified when there's something new on the Anemia in CKD: Daprodustat ASCEND-TD Clinical Trial page.

Latest updates to the Anemia in CKD: Daprodustat ASCEND-TD Clinical Trial page
- Check2 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden response.SummaryDifference0.2%

- Check9 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The page content below remains a 403 Forbidden error.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page now shows a 403 Forbidden error page, with the site header and footer visible but no study details. This indicates restricted access rather than an update to the study content.SummaryDifference0.5%

- Check44 days agoChange DetectedThe study page now shows a 403 error instead of the study details, indicating that the record cannot be loaded and is inaccessible to users.SummaryDifference18%

Stay in the know with updates to Anemia in CKD: Daprodustat ASCEND-TD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anemia in CKD: Daprodustat ASCEND-TD Clinical Trial page.